Assembly Biosciences
ASMB
32 hedge funds and large institutions have $8.44M invested in Assembly Biosciences in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 32 → 32 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.16% less ownership
Funds ownership: 1.67% → 1.51% (-0.16%)
30% less capital invested
Capital invested by funds: $12M → $8.44M (-$3.59M)
75% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$45.1K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$25.3K |
| 3 |
JP Morgan Chase
New York
|
+$60 |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$48 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$12 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$629K |
| 2 |
Renaissance Technologies
New York
|
-$205K |
| 3 |
Millennium Management
New York
|
-$36.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33.9K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$30.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
RhumbLine Advisers
Boston,
Massachusetts
| $2.12K | – | – | – |
|
|
BAAM
27
Baker Avenue Asset Management
San Francisco,
California
| $885 | – | – | – |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $443 | – | – | – |
|
|
29
Wells Fargo
San Francisco,
California
| $340 | +$12 | +1 | +3% |
|
|
30
JP Morgan Chase
New York
| $137 | +$60 | +5 | +63% |
|
|
31
Qube Research & Technologies (QRT)
London,
United Kingdom
| $38 | +$48 | +4 | New |
|
32
BNP Paribas Financial Markets
Paris,
France
| $28 | – | – | – |
|
33
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$13.9K | -1,006 | Closed |
|
ASMB Hedge Fund Activity: Q3 2023 in Review
32 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2023, worth a combined $8.44M — down 30% from $12M a quarter earlier.
Fund positioning in ASMB was balanced in Q3 2023: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 12 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $45.1K. The largest seller was Hudson Bay Capital Management, cutting an estimated $629K.
- 32 institutional investors held Assembly Biosciences (ASMB) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $8.44M of Assembly Biosciences stock for Q3 2023, down 30% quarter-over-quarter.
- 2 funds opened new Assembly Biosciences positions in Q3 2023 and 2 closed out, a net change of 0 holders.
- The largest Assembly Biosciences buyer in Q3 2023 was Citadel Advisors, an estimated $45.1K added.
- The largest Assembly Biosciences seller in Q3 2023 was Hudson Bay Capital Management, an estimated $629K sold.
Based on aggregated 13F filings for Q3 2023.